Your browser doesn't support javascript.
loading
Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials.
Wells, J Connor; Sidhu, Aven; Ding, Keyue; Smoragiewicz, Martin; Heng, Daniel Y C; Shepherd, Frances A; Ellis, Peter M; Bradbury, Penelope A; Jonker, Derek J; Siu, Lillian L; Gelmon, Karen A; Karapetis, Christos; Shapiro, Jeremy; Nott, Louise; O'Callaghan, Christopher J; Parulekar, Wendy R; Seymour, Lesley; Monzon, Jose G.
Affiliation
  • Wells JC; Queen's University, Kingston, ON, Canada.
  • Sidhu A; Fraser Health and Veralife Health Centre, Surrey, BC, Canada.
  • Ding K; Canadian Cancer Trials Group, Kingston, ON, Canada.
  • Smoragiewicz M; Canadian Cancer Trials Group, Kingston, ON, Canada.
  • Heng DYC; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada.
  • Shepherd FA; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Ellis PM; Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON, Canada.
  • Bradbury PA; The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
  • Jonker DJ; BC Cancer Agency, Vancouver, BC, Canada.
  • Siu LL; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Gelmon KA; BC Cancer Agency, Vancouver, BC, Canada.
  • Karapetis C; Flinders Medical Centre and Flinders University, Adelaide, Australia.
  • Shapiro J; Cabrini Health, Melbourne, Australia.
  • Nott L; Royal Hobart Hospital, Tasmania, Australia.
  • O'Callaghan CJ; Canadian Cancer Trials Group, Kingston, ON, Canada.
  • Parulekar WR; Canadian Cancer Trials Group, Kingston, ON, Canada.
  • Seymour L; Canadian Cancer Trials Group, Kingston, ON, Canada.
  • Monzon JG; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada.
Oncologist ; 27(3): e286-e293, 2022 03 11.
Article in En | MEDLINE | ID: mdl-35274718
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Complementary Therapies / Clinical Trials, Phase III as Topic / Neoplasm Metastasis Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: Canada
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Complementary Therapies / Clinical Trials, Phase III as Topic / Neoplasm Metastasis Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: Canada